The challenge
Wounds of different aetiologies are a challenge for the patient, the health professional and health-care systems. An adequate treatment right from the start may be essential for the final outcome.
Sorbact
Wounds of different aetiologies are a challenge for the patient, the health professional and health-care systems. An adequate treatment right from the start may be essential for the final outcome.
The killing of bacteria means endotoxins are released from dead cells and cell debris is left in the wound. So, unlike antimicrobial dressings that actively kill bacteria, Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing.
Proven in more than 40 clinical studies and in publications including over 7,000 patients, Sorbact® has more than 30 years of successful use in clinical practice. Today Sorbact® is helping patients in over 65 countries around the world and we are continuing this important work by collecting clinical data.
Read moreAbigo Medical is a Swedish life science company founded in 1989. Since 2021, Abigo Medical is owned by the global hygiene and health company Essity and part of Business Area Health and Medical. We are dedicated to improving well-being through leading hygiene and health solutions.
Read more